Skip to content

Adent

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Geerdegem-Schonenberg 58 ·2800 Mechelen, Belgium
KBO/BCE: BE 0786.916.854
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Adent is 0.2% (very low). The 2024 annual accounts show equity of €41k and a net result of €38k. Equity is growing by ~21.9% per year across the filed fiscal years. Its solvency ranks better than 95% of 6574 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

2 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 95% of 6574 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 13 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 28-08-2025 28 d late 2025-00446354
31-12-2023 31-07-2024 29-09-2024 60 d late 2024-00492085
31-12-2022 31-07-2023 29-09-2023 60 d late 2023-00465651

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€38k+2.8%
Working capital€41k-31.3%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 28-08-2025 with the NBB · fiscal year 2024 · micro
€0€20k€40k€60kOperating result 2022: €26k€26kNet result 2022: €20k€20kOperating result 2023: €47k€47kNet result 2023: €37k€37kOperating result 2024: €51k€51kNet result 2024: €38k€38k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~21.9%/year over 3 fiscal years, indicative, assuming unchanged policy.
€20k€40k€60k€80k2025: €51k (€47k - €54k)2026: €60k (€56k - €63k)2027: €69k (€65k - €72k)2022: €23k2023: €60k2024: €41k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 97.7% 66.7%
better than 95% of 6574 sector peers
Net result €38k €46k
better than 44% of 6568 sector peers
Equity €41k €79k
better than 32% of 6574 sector peers
Gross operating margin €53k €78k
better than 36% of 6576 sector peers
Total assets €42k €154k
better than 12% of 6577 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P95
2022: P95 · n=36682023: P94 · n=53302024: P95 · n=65742022 2024
Stable position over 2022-2024 · n=3668-6574
Net result P44
2022: P33 · n=36662023: P49 · n=53292024: P44 · n=65682022 2024
Stable position over 2022-2024 · n=3666-6568
Equity P32
2022: P27 · n=36682023: P47 · n=53322024: P32 · n=65742022 2024
Stable position over 2022-2024 · n=3668-6574
Gross operating margin P36
2022: P24 · n=36642023: P38 · n=53262024: P36 · n=65762022 2024
Improving position over 2022-2024 · n=3664-6576
Describes the position versus peers, not a forecast.
Net profit
€38k
+2.8% 22-24
Total assets
€42k
-33.7% 22-24
Equity
€41k
-31.3% 22-24
Working capital
€41k
-31.3% 22-24
Income taxes
€11k
+19.8% 22-24
Dividends
€57k
- 22-24
Debt
€966
-73.1% 22-24
Debt ≤ 1y
€966
-73.1% 22-24
Current ratio
43.90
+146.5% 22-24
Quick ratio
43.90
+146.5% 22-24
Solvency
97.7%
+3.5% 22-24
Debt / equity
0.02
-60.8% 22-24
ROE
92.0%
+49.7% 22-24
ROA
89.9%
+55.0% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA-
Net profit€38k
Cash flow-
Staff costs-
Income taxes€11k
Dividends€57k
Total assets€42k
Equity€41k
Debt€966
of which ≤ 1y€966
of which > 1y-
Working capital€41k
Employees (FTE)-
Ratios (computed)
2024
Current ratio43.90
Quick ratio43.90
Working capital ratio97.7%
Solvency97.7%
Debt / equity0.02
Long-term debt ratio-
Interest coverage-
Gross margin-
Net margin-
ROA89.9%
ROE92.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€42k
Current assets 29/58€42k
Amounts receivable within one year 40/41€3k
Cash & bank 54/58€19k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€42k
Equity 10/15€41k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€38k
Amounts payable 17/49€966
Amounts payable within one year 42/48€966
Trade debts payable within one year 44€175
Income statement
Gross operating margin 9900€53k
Operating result 9901€51k
Financial charges 65€1k
Result before taxes 9903€50k
Income taxes 67/77€11k
Net result for the period 9904€38k
Result to be appropriated 9905€38k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
90 / 100 Excellent
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Geerdegem-Schonenberg 582800 Mechelen

Establishment units

1 location
Adent
Geerdegem-Schonenberg 58, 2800 MechelenActiviteiten van tandartspraktijken
since 20222.332.202.078
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area249 m²
Buildings1
Building footprint86 m²
Volume (LiDAR)90 m³
Tallest building7.6 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12403E0121/00Y002 Flanders 249 m² 1 · 86 m² 7.6 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
22-12-2022
Registered-office move
All acts · 1 updated 3 years ago
2022
22-12-2022 Registered office moved within Mechelen Registered-office change
  • Schorsmolenstraat 32/bus E002-2800 Mechelen → Geerdegem Schonenberg 58 te 2800 Mechelen

Analysis

Snowflake analysis

financial profile on 5 axes
Health90Profitability100Solvency100Growth78Stability94
92 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 90
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
Legal nameNL Adent
Registered office
Geerdegem-Schonenberg 58
2800 Mechelen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.